HapMap-based study identifies risk sub-region on chromosome 19q13.3 in relation to lung cancer among Chinese

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 923-929

  Yin, Jiaoyang ^a   Vogel, Ulla ^b   Wang, Huiwen ^a   Ma, Yegang ^c   Wang, Chunhong ^a   Liang, Duohong ^a   Liu, Jian ^a   Yue, Li ^d   Zhao, Yudan ^a   Ma, Jian ^a  

^a SHENYANG MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^d JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chinese; Chromosome 19q13.3; ERCC2, PPP1R13L, CD3EAP and ERCC1; HapMap database; HtSNP; Lung cancer

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CHINESE; CHROMOSOME 19Q; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE MAP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

CHINESE; CHROMOSOME 19Q13.3; ERCC2, PPP1R13L, CD3EAP AND ERCC1; HAPMAP DATABASE; HTSNP; LUNG CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HAPMAP PROJECT; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84888302707     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.09.016     Document Type: Article

References (29)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917.
2. Chen Z. Medical genetics 2001, 262-263. People Hygienic Press, Beijing, China. 1st ed.
3. Rockenbauer E., Bendixen M.H., Bukowy Z., Yin J., Jacobsen N.R., Hedayati M., et al. Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts. Carcinogenesis 2002, 23(7):1149-1153.
4. Yin J., Rockenbauer E., Hedayati M., Jacobsen N.R., Vogel U., Grossman L., et al. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of Basal cell carcinoma. Cancer Epidemiol Biomark Prev 2002, 11(11):1449-1453.
5. Yin J., Vogel U., Gerdes L.U., Dybdahl M., Nexo B.A. Twelve single nucleotide polymorphisms on chromosome 19q13.2-3: linkage disequilibria and associations with basal cell carcinoma in Danish psoriatic patients. Biochem Genet 2003, 41(1-2):27-37.
6. Nexø B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., et al. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55. Carcinogenesis 2003, 24(5):899-904.
7. Nexø B.A., Vogel U., Olsen A., Nyegaard M., Bukowy Z., Rockenbauer E., et al. Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP. BMC Med Genet 2008, 9:56.
8. Schierup M.H., Mailund T., Li H., Wang J., Tjønneland A., Vogel U., et al. Haplotype frequencies in a sub-region of chromosome 19q13.3, related to risk and prognosis of cancer, differ dramatically between ethnic groups. BMC Med Genet 2009, 10:20.
9. Vogel U., Laros I., Jacobsen N.R., Thomsen B.L., Bak H., Olsen A., et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 2004, 546(1-2):65-74.
10. Yin J., Vogel U., Ma Y., Qi R., Wang H. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population. Mutat Res 2008, 641(1-2):12-18.
11. Yang P., Kollmeyer T.M., Buckner K., Bamlet W., Ballman K.V., Jenkins R.B. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas. Cancer 2005, 103(11):2363-2372.
12. Skjelbred C.F., Saebø M., Nexø B.A., Wallin H., Hansteen I.L., Vogel U., et al. Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study. BMC Cancer 2006, 6:175.
13. Ricceri F., Guarrera S., Sacerdote C., Polidoro S., Allione A., Fontana D., et al. ERCC1 haplotypes modify bladder cancer risk: a case-control study. DNA Repair 2010, 9(2):191-200.
14. Yin J., Vogel U., Ma Y., Qi R., Wang H. HapMap-based study of the DNA repair Gene ERCC2 and lung cancer susceptibility in a Chinese population. Carcinogenesis 2009, 7(30):1181-1185.
15. Yin J., Vogel U., Ma Y., Qi R., Wang H., Yue L., et al. HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population. Mutat Res 2011, 713(1-2):1-7.
16. Yin J., Vogel U., Wang C., Laing D., Ma Y., Wang H., et al. HapMap-based evaluation of ERCC2, PPP1R13L and ERCC1 and lung cancer risk in a Chinese population. Environ Mol Mutagen 2012, 53(3):239-245.
17. Vogel U., Sørensen M., Hansen R.D., Tjønneland A., Overvad K., Wallin H., et al. Gene-environment interactions between smoking and a haplotype of RAI, ASE-1 and ERCC1 polymorphisms among women in relation to risk of lung cancer in a population-based study. Cancer Lett 2007, 247(1):159-165.
18. Xiao Z., Xiao J., Jiang Y., Zhang S., Yu M., Zhao J., et al. A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol Res 2006, 34(3):150-155.
19. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15(2):97-98.
20. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
21. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
22. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., et al. Mulltifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69(1):138-147.
23. Moore J.H., Gilbert J.C., Tsai C.T., Chiang F.T., Holden T., Barney N., et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006, 241(2):252-261.
24. Whitehead C.M., Winkfein R.J., Fritzler M.J., Rattner J.B. ASE-1: a novel protein of the fibrillar centres of the nucleolus and nucleolus organizer region of mitotic chromosomes. Chromosoma 1997, 106(8):493-502.
25. Yamazaki T., Hamano Y., Tashiro H., Itoh K., Nakano H., Miyatake S., et al. CAST, a novel CD3epsilon-binding protein transducing activation signal for interleukin-2 production in T cells. J Biol Chem 1999, 274(26):18173-18180.
26. Yamamoto K., Yamamoto M., Hanada K., Nogi Y., Matsuyama T., Muramatsu M. Multiple protein-protein interactions by RNA polymerase I-associated factor PAF49 and role of PAF49 in rRNA transcription. Mol Cell Biol 2004, 24(14):6338-6349.
27. Veeramachaneni V., Makałowski W., Galdzicki M., Sood R., Makałowska I. Mammalian overlapping genes: the comparative perspective. Genome Res 2004, 14(2):280-286.
28. Chen P., Wiencke J., Aldape K., Kesler-Diaz A., Miike R., Kelsey K., et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000, 9(8):843-847.
29. Yin J., Vogel U., Ma Y., Wang H., Wang C., Liang D., et al. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population. Lung Cancer 2012, 76(3):286-291.